Overview
Yu Xiao practices in Chengdu, China. Xiao is rated as an Advanced expert by MediFind in the treatment of COVID-19. Their top areas of expertise are Severe Acute Respiratory Syndrome (SARS), Tufted Angioma, COVID-19, and Hemangioma.
Their clinical research consists of co-authoring 70 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 14 articles in the study of COVID-19.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Xiao isAdvanced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)
- Tufted AngiomaXiao isAdvanced. Learn about Tufted Angioma.
- Experienced
- Autoimmune HepatitisXiao isExperienced. Learn about Autoimmune Hepatitis.
- HemangiomaXiao isExperienced. Learn about Hemangioma.
- Memory LossXiao isExperienced. Learn about Memory Loss.